Cashu
Illumina Collaborates with IPRD to Advance Diagnostics for Pediatric Rare Diseases
2 days ago
Stocks
Health Care
ilmn
Illumina
NASDAQ: ILMN
-1.53 (0.00%)
132.93
USD
At close at Mar 03, 14:26 UTC
Overview
Loading chart...
Key Stats
Market Cap
20.31B
Dividend Yield
0.00%
P/E Ratio
23.89
EPS
-7.67
Revenue
4.37B
Avg. Volume
2.80M
About
What does ILMN do?
Illumina, headquartered in San Diego, develops life science tools for genetic analysis, employing 10,590 staff since its IPO in 2000. Its products span various applications, including oncology and agriculture.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.